This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Beneficial effects of omega-3 fatty acid supplementation in schizophrenia: possible mechanisms
Lipids in Health and Disease Open Access 03 July 2020
-
Diverse definitions of the early course of schizophrenia—a targeted literature review
npj Schizophrenia Open Access 15 October 2018
-
Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis
Molecular Psychiatry Open Access 16 August 2018
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
Jaaro-Peled H, Hayashi-Takagi A, Seshadri S, Kamiya A, Brandon NJ, Sawa A . Trends Neurosci 2009; 32: 485–495.
Seidman LJ, Giuliano AJ, Meyer EC, Addington J, Cadenhead KS, Cannon TD et al. Arch Gen Psychiatry 2010; 67: 578–588.
Mittal VA, Neumann C, Saczawa M, Walker EF . Arch Gen Psychiatry 2008; 65: 165–171.
Do KQ, Cabungcal JH, Frank A, Steullet P, Cuenod M . Curr Opin Neurobiol 2009; 19: 220–230.
Tarawneh R, Holtzman DM . Neuropharmacology 2010; 59: 310–322.
Chattopadhyay M, Valentine JS . Antioxid Redox Signal 2009; 11: 1603–1614.
DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP et al. Science 1997; 277: 1990–1993.
Urushitani M, Ezzi SA, Julien JP . Proc Natl Acad Sci USA 2007; 104: 2495–2500.
Ottis P, Bader V, Trossbach SV, Kretzschmar H, Michel M, Leliveld SR et al. Biol Psychiatry 2011; 70: 604–610.
Padurariu M, Ciobica A, Dobrin I, Stefanescu C . Neurosci Lett 2010; 479: 317–320.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Molecular Psychiatry website
Supplementary information
Rights and permissions
About this article
Cite this article
Coughlin, J., Ishizuka, K., Kano, S. et al. Marked reduction of soluble superoxide dismutase-1 (SOD1) in cerebrospinal fluid of patients with recent-onset schizophrenia. Mol Psychiatry 18, 10–11 (2013). https://doi.org/10.1038/mp.2012.6
Published:
Issue date:
DOI: https://doi.org/10.1038/mp.2012.6
This article is cited by
-
Biomarkers in the cerebrospinal fluid of patients with psychotic disorders compared to healthy controls: a systematic review and meta-analysis
Molecular Psychiatry (2023)
-
Beneficial effects of omega-3 fatty acid supplementation in schizophrenia: possible mechanisms
Lipids in Health and Disease (2020)
-
Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis
Molecular Psychiatry (2019)
-
Reconceptualization of translocator protein as a biomarker of neuroinflammation in psychiatry
Molecular Psychiatry (2018)
-
Diverse definitions of the early course of schizophrenia—a targeted literature review
npj Schizophrenia (2018)